Showing results (151-160 of 463) with videos related to

Sort By:
Pageof 47
Clinical Neuropharmacology|February 3, 2007
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson diseaseFabrizio Stocchi, Laura Fabbri, Laszlo Vecsei, et al.
Expert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorderFabrizio Stocchi, Giampetro Nordera, Riitta H Jokinen, et al.
Journal of Neurology|January 16, 2007
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's diseaseAstrid Thomas, Laura Bonanni, Angelo Di Iorio, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2023
Exploring depression in Alzheimer's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementAlessandro Padovani, Angelo Antonini, Paolo Barone, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2025
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's diseaseManon Auffret, Fran Borovecki, Beatrice Heim, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 26, 2023
Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementFabrizio Stocchi, Angelo Antonini, Paolo Barone, et al.
Pageof 47